Compare Medtronic PLC (MDT) vs Nutanix Inc (NTNX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Nutanix Inc — how do they compare? Medtronic PLC trades at $88.48 (market cap $112.24B), while Nutanix Inc trades at $74.63 (market cap $19.78B). The key difference: Medtronic PLC is far larger — about 5.7× Nutanix Inc's market cap, and Medtronic PLC pays a 3.28% dividend while Nutanix Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Nutanix Inc for 17 Days on average.
| MDT | NTNX | |
|---|---|---|
Market Cap | $112.24B | $19.78B |
Volume | 105,663,236 | 1,717,619 |
Sector | Health | Technology |
52-Week High | $105.35 | $74.63 |
52-Week Low | $73.75 | $34.41 |
Typical Hold Time | 63 Days | 17 Days |
Enterprise Value | $131.58B | $18.94B |
Dividend Yield | 3.28% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.75, up 2.62% today, with strong fundamental performance including three consecutive quarterly earnings beats and a 49-year dividend growth streak. The stock shows bearish technical signals but maintains solid profitability with 13.93% net margins and positive cash flow trends. Recent regulatory approvals for medical devices and raised guidance signal operational momentum despite mixed technical indicators.
Outlook remains positive with analyst consensus at $97.80 (11% upside) and no sell ratings, though technical weakness and increasing debt-to-asset ratios pose near-term risks. The 3.2% dividend yield provides income support while revenue growth acceleration to $37.5B projected for 2026 offers growth potential.
Nutanix (NTNX) trades at $73.08, down 0.46% on the day, with strong technical momentum indicated by bullish moving averages. The company demonstrates robust fundamentals with consistent earnings beats, including Q2 2026 EPS of $0.60 beating expectations of $0.49, and impressive net income margin expansion to 52.81% in 2026. Recent Gartner Magic Quadrant recognitions highlight competitive strength in server virtualization and container management.
The outlook remains positive with analyst consensus targeting $76.11, though elevated valuation ratios and negative ROE present risks. Key catalysts include external storage growth and AI initiatives, while supply chain pressures and competitive threats warrant monitoring. The stock's proximity to resistance at $74 suggests potential near-term consolidation before further upside.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Nutanix Inc
Nutanix, Inc. is a global leader in cloud software and hyperconverged infrastructure (HCI) solutions. The company's platform converges computing, virtualization, and storage into a single, seamless software-defined solution, enabling private, hybrid, and multi-cloud environments. Nutanix helps organizations simplify data center operations, manage their applications across various cloud platforms, and reduce IT complexity, positioning it as a key enabler of modern hybrid cloud strategies.
Read more on NTNX →
